Concentrations of choline and its metabolites were measured in plasma collected during the Day 1 clinic visit as described in Methods. For rs12676 N = 40 (GG), 30 (GT) and 6 (TT). For rs1025689 N = 15
A summary of genotypic differences observed in the neurological and behavioral screens is shown, with male and female results shown separately. Ages at which the indicated tests were performed are als
H3K27ac ChIP-seq on middle frontal area 46 tissue female adult (90 or above years) with Alzheimer's disease. For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and ht